Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Regeneron Pharmaceuticals : Assigned Patent

07/02/2015 | 07:34am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., July 2 -- Regeneron Pharmaceuticals, Tarrytown, New York, has been assigned a patent (9,066,502) developed by five co-inventors for "hybrid light chain mice." The co-inventors are Lynn Macdonald, White Plains, New York, Sean Stevens, San Diego, Cagan Gurer, Valhalla, New York, Andrew J. Murphy, Croton-on-Hudson, New York, and Karolina A. Meagher, Tarrytown, New York.

The patent application was filed on Dec. 18, 2013 (14/132,412). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=90,66,502.PN.&OS=PN/90,66,502&RS=PN/90,66,502

Written by Amal Ahmed; edited by Jaya Anand.

AM0702JA0702-1122968 93JAnand

(c) 2015 Targeted News Service, source News Service

React to this article
Latest news on REGENERON PHARMACEUTICALS
07/02 REGENERON PHARMACEUTICALS : Assigned Patent
07/01 REGENERON PHARMACEUTICALS : Robbins Arroyo LLP : Is Investigating Regeneron Phar..
07/01 REGENERON PHARMACEUTICALS : EYLEA® aflibercept Injection Receives Approval in Ja..
07/01 REGENERON PHARMACEUTICALS : Announces 2015 Winners of the Prize for Creative Inn..
06/29 REGENERON PHARMACEUTICALS : Rapid Response Platform for Emerging Infectious Dise..
06/26 New Sanofi CEO to unveil five-year plan in November - unions
06/26 REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Receives Approval in ..
06/25 REGENERON PHARMACEUTICALS : Announces 2015 Winners of the Prize for Creative Inn..
06/23 REGENERON PHARMACEUTICALS : Federal Contracts Awarded by Federal Agencies in Ill..
06/23 REGENERON PHARMACEUTICALS : $470 Million Federal Contract Awarded to Regeneron P..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
More Financials